SMS Pharmaceuticals Ltd

SMSPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹738 cr, stock is ranked 1,119
Moderate RiskStock is 2.60x as volatile as Nifty
87.252.90 (+3.44%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹738 cr, stock is ranked 1,119
Moderate RiskStock is 2.60x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
11.82
PB RatioPB Ratio
1.80
Dividend YieldDiv. Yield
0.34%
Sector PESector PE
33.53
Sector PBSector PB
4.83
Sector Div YldSctr Div Yld
0.83%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

SMS Pharmaceuticals Limited is engaged in manufacturing and sale of bulk drugs and active pharmaceutical ingredients (APIs), and their intermediates.

Investor PresentationView older 

Feb 10, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021465.07468.31417.06566.6231.7740.0431.5762.51
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

General updates 
Announced OnMay 6, 2022

Approval for Reclassification of shareholders from ¬タリPromoter and Promoter Group¬タル to ¬タリPublic¬タル category under Regulation 31A of SEBI (LODR) Regulations, 2015 | Download

Approval for Reclassification of shareholders from ¬タリPromoter and Promoter Group¬タル to ¬タリPublic¬タル category under Regulation 31A of SEBI (LODR) Regulations, 2015 | Download

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnApr 12, 2022

SMS Pharmaceuticals Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

SMS Pharmaceuticals Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Cash Dividend 
Ex. DateSep 22, 2021

Final • Div/Share: ₹ 0.3

See all events